Barclays Downgrades Cigna Amid Concerns Over PBM Transition
On May 26, Barclays downgraded Cigna (CI) to Equal Weight from Overweight and reduced its price target to $304. The downgrade was driven by concerns over limited earnings upside due to low exposure to government insurance programs and uncertainty around the company's pharmacy benefit manager transition.
Topics: analyst downgrade Barclays Cigna investment outlook PBM transition